Skip to main content
. 2019 Dec 11;14(4):500–508. doi: 10.5009/gnl19155

Fig. 3.

Fig. 3

Cumulative survival rates at 6 weeks based on the MELD score and BCLC stage. The risk of 6-week mortality was significantly higher among patients with a MELD score ≥15.5 and BCLC stage C–D than among patients with a lower MELD score and earlier BCLC stage (log-rank test p<0.001).

MELD, Model for End-Stage Liver Disease; BCLC, Barcelona Clinic Liver Cancer.